Study Group: Humira Prescribers for Arthritis: Rheumatologists (US)(?)
Council Members in this Study Group: 64
Request a survey with this Study Group
Leading Experts in this Study Group
Partner
San Diego Arthritis Medical Clinic
Ara Dikranian, MD, is a Rheumatologist at San Diego Arthritis Medical Clinic, a single-specialty private practice in San Diego, California. Dr. Dikranian is board certified in Internal Medicine and Rheumatology. He completed his rheumatology training at the University of California San Diego. He has...
Herbert Baraf, MD, FACP, FACRClinical Associate Professor of Medicine
UNIVERSITY OF MARYLAND
Herbert Baraf, MD, FACP, FACR, is the Managing Partner of Arthritis and Rheumatism Associates and the Medical Director of Center for Rheumatology and Bone Research in Maryland. He is also the Clinical Professor of Medicine at George Washington University Medical Center and Clinical Associate Professor...
Rheumatologist
HEALTHCARE PARTNERS MEDICAL GROUP
Dipti Doshi, MD, is a board certified Rheumatologist at Health Care Partners Medical group, California. Dr. Doshi is also board certified in Internal Medicine. Her special interests are in rheumatoid arthritis, lupus, pain-related to scleroderma, fibromyalgia, and osteoarthritis. Dr. Doshi is interested...
Avram Goldberg, MD,FACRAssistant Professor
Albert Einstein College of Medicine
Avram Goldberg, MD, FACR, is an Attending Physician at North Shore University Hospital and an Assistant Professor at the Albert Einstein College of Medicine, New York. He is part of the Division of Rheumatology where he is responsible for treatment of autoimmune and musculoskeletal diseases including...
Rheumatologist
Arthritis and Osteoporosis Treatment Center
Kenneth Nies, MD, FACP, is a Clinical Professor of Medicine at the University of California Los Angeles and is also in private practice at the Arthritis and Osteoporosis Treatment Center in Torrance, California. In addition to his clinical work, his background includes 10 years of academic medicine...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
This should not deter the practicing physician to prescribe these agents osteoporosis will reach epidemic proportions and if we can reduce fractures by 50% the savings within the healthcare system will be enormous that's not to say that individuals albeit rare may have a propensity to develop fractures...
Drug therapies for RA include (NSAIDS), DMARDS, and, most recently, biologics. Biologics currently on the market for RA target immune messengers called cytokines, which promote the damaging inflammatory process, and include anti-tumor necrosis factor (TNF) drugs – infliximab , etanercept,adalimumab,...
A delay in instituting aggressive antirheumatic medications such as the biologic response modifiers has long term implications in irreversible joint damage. Cost considerations (particularly with the looming potential of "universal healthcare" under a new administrations promises) with exponentially...
New Osteoporosis Drug Reduces Mortality after Hip Fracture without increase in Cardiovascular Events
In a recent hip fracture intervention trial released on the New England Journal of Medicine website by Lyles, et al on Sept 17,2007 (not scheduled to be released in print until Nov 1 2007) Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture A placebo controlled study...
Pharmacokinetic studies of Adlea showed that when it is locally administered to the site of pain, there appears to be limited systemic exposure. Its short duration of systemic exposure (hours) relative to the long duration of analgesia (12 weeks) resulting from a single treatment course of Adlea is...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Academic Institution*
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Director
- Owner
- Physician - Division Head
- President
- Partner
- Medical Director
- Professor